Upgrade to see committee overlap, performance context, and full expert analysis.
IVZ congressional trades
3 matched disclosures
IVZ congressional trades snapshot
This page summarizes public STOCK Act disclosures involving IVZ. It is useful for seeing which lawmakers reported IVZ transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Apr 3, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
What the IVZ congressional trade page shows
Congressional Trader tracks 3 public STOCK Act disclosures for IVZacross 3 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent IVZ filing shown here was filed on Apr 3, 2026 by Kevin Hern as a sale. Related lawmakers include Gilbert Ray Cisneros, Kevin Hern, Robert P. Bresnahan.
Top lawmakers for IVZ
Pro performance summary
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansUpgrade to see committee overlap, performance context, and full expert analysis.
Upgrade to see committee overlap, performance context, and full expert analysis.
FAQ
Which lawmakers traded IVZ?
Recent IVZ disclosures include Gilbert Ray Cisneros, Kevin Hern, Robert P. Bresnahan.
What is the buy/sell mix for IVZ?
The visible sample currently shows 1 purchases and 2 sales or partial sales.
Should I trade based on IVZ disclosures?
No. This page summarizes public filings for research and monitoring. It is not investment advice.